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ABSTRACT 
OBJECTIVE: It is unclear whether the association between osteoarthritis (OA) and metabolic 
syndrome (MetS) varies with the site of the affected joint and the presence of pain. Our aim 
was to describe the association between MetS and radiographic OA (ROA) affecting the knee 
or the hand in the presence or absence of concurrent joint pain. 
METHODS: Cross-sectional data of 952 women, aged 45-65 years from from the Chingford 
study, a population-based longitudinal cohort of middle-aged women initiated in 1988-1989 in 
London (UK), was analysed. MetS was defined using the National Cholesterol Education 
Program Treatment Panel III criteria. Data was collected on components of MetS: waist 
circumference, triglycerides, high-density lipoprotein (HDL), blood pressure and blood 
glucose. The outcome was four knee and hand OA groups: painful ROA, ROA only, pain only 
and neither ROA nor pain (reference category). Multinomial logistic regression models 
adjusted for age and body mass index (BMI) were used to evaluate the effect of presence of 
MetS and its individual components on OA subgroups for knee and hand separately. 
RESULTS: 952 eligible women, aged 45-65 years was analysed. A significant association was 
observed between the presence and the number of MetS with painful knee ROA when adjusted 
for age; however, this association disappeared when BMI was included in the model. In 
contrast, the presence and the number of MetS were associated with painful interphalangeal 
(IPJ) OA after adjusting for both age and BMI. Four out of the five MetS components, including 
triglycerides, HDL-c, hypertension and glucose, were associated with painful IPJ OA.  
CONCLUSIONS: MetS is associated with painful IPJ OA but not with knee OA once BMI is 
taking into consideration.  Further attention to MetS and OA at different sites is needed to 
understand the metabolic phenotype in OA. 
Keywords: Metabolic syndrome, hand, knee, osteoarthritis, pain 
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1. INTRODUCTION 
Osteoarthritis (OA) is the most common form of arthritis and a leading cause of disability in 
the developed world 1. The natural history of OA is poorly understood; it is recognised as a 
heterogeneous disease of multifactorial aetiology with shared common radiographic features 
and symptomatology 2,3.  
A higher prevalence of metabolic syndrome (MetS), defined as high waist circumference, 
dyslipidaemia (low high-density lipoprotein (HDL) and triglyceridaemia), hypertension and 
insulin resistance, has been reported in patients with OA, even after controlling for identified 
risk factors such as age, sex and body mass index (BMI) or weight 4-7. Two previous systematic 
reviews with meta-analyses suggested a strong association between diabetes and OA, 
independent of weight and BMI8,9. In contrast, a recent systematic review found little evidence 
to support an association between DM and knee OA and no evidence with hip or hand OA was 
found10. A recent meta-analysis demonstrated that hypertension was associated with both 
radiographic and symptomatic knee OA11, and another systematic review demonstrated an 
association between dyslipidemia and OA12. 
There is evidence for a relationship between visceral fat tissue13,14, metabolic syndrome (MetS) 
15-17 and OA and this is expected to translate into higher cardiovascular risk18 and premature 
mortality.  
The association between knee and hand OA with systemic metabolic dysregulation is 
controversial. Previous studies of MetS and OA focussed on selected groups of individuals 
with potential confounding by recruitment strategy (often associated with the severity of 
disease).  The Netherlands Epidemiology of Obesity study looked at components of MetS and 
surrogates of mechanical stress in a general population cohort that over-sampled obese and 
overweight individuals 16. This cross-sectional study demonstrated that individuals with MetS 
were more likely to have hand and knee OA, even after adjusting for age, sex, smoking, 
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ethnicity and height. In knee OA, this relationship was not significant after adjusting for weight 
indicating the importance of increased mechanical load on the lower limb joints. Interestingly, 
the association of MetS and hand OA remained significant even after adjusting for weight.  
Most previous studies have focused their attention on lower limb OA and/or radiographic hand 
OA, however to the best of our knowledge none has studied the association between the 
accumulation of metabolic factors and painful hand ROA.  
The aims of our study were: 1) to assess the association of components of MetS, either singly 
or additively, with painful and painless ROA affecting two different sites (knee or hand) and, 
2) to describe whether this association varies with the site of the affected joint in a community-
based cohort of middle-aged women. 
 
2. METHODS 
We used cross-sectional data from the Chingford 1000 Women Study, a prospective 
population-based longitudinal cohort of middle-aged women19. All women aged 45 or above 
and registered at a general practice in Chingford (North London, UK) were contacted in 1988-
1989 and asked to participate. Out of 1353 women contacted, 1003 (78% response rate) 
attended the baseline visit. The cohort has been shown to be representative of this group of 
women in England in terms of basic characteristics, with the exception of a lower rate of current 
smokers 19-23.  
The study was approved by the local ethics committee and written consent was obtained from 
all participants. 
2.1.Exclusion criteria 
We excluded women with rheumatoid arthritis (RA) and those who did not have data available 
on either knee or hand pain and/or radiographic at baseline (ntotal=51). 
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2.2.Assessment of joint-specific radiographic OA and pain (outcome) 
A physical examination was performed at baseline, with anteroposterior (AP) radiographs of 
the hands and weight-bearing anteroposterior view (AP) radiographs of the knee. The protocols 
for radiographic grading and reproducibility for knee and hand ROA have been previously 
reported 22,24. Women were classified as having knee ROA if they had a Kellgren–Lawrence 
(K/L) OA grade of ≥2 in at least one knee. Hand radiographs were also graded for OA: 
summary scores of distal and proximal interphalangeal (DIP and PIP) joints were defined as 
the number of joints with K/L grade ≥2, while hand ROA in any  interphalangeal joint (IPJ) 
was defined as positive if the K/L score in at least one joint was ≥2. 
Knee and hand pain was assessed as part of a standardised joint symptom questionnaire 
administered by a nurse. It contained information on onset, duration (months), and presence 
(yes/no) for each one of the three following symptoms: pain, stiffness and swelling. Knees and 
hands were considered to be symptomatic if pain and/or stiffness in the knee or DIP and PIP 
joints was reported to be present. 
The sample was divided into four mutually exclusive subgroups based on the presence or 
absence of pain and ROA 25: 
 
1. Neither ROA nor pain (Pain−/ROA−; reference category). 
2. ROA only (Pain−/ROA+) 
3. Pain only (Pain+/ROA−) 
4. Painful ROA (Pain+/ROA+: joint(s) with ROA and pain or stiffness affecting the same site) 
 
Women with ROA at one site and pain only at the contralateral site were classified as having 
ROA-/Pain+ (n=4 and n=3 women for knee and hand, respectively), because we used the 
‘highest’ category based on this OA classification. 
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2.3.Metabolic syndrome (exposure) 
MetS was defined according to the Joint Scientific Statement National Cholesterol Education 
Program III 26. Presence of MetS was diagnosed when 3 or more of the following criteria were 
met: elevated waist circumference (≥88 cm), elevated serum triglycerides (≥1.7 mmol/L), 
reduced high-density lipoprotein cholesterol (HDL-c) (<1.3 mmol/L), hypertension (systolic 
blood pressure ≥130 mmHg and/or diastolic blood pressure ≥85 mmHg) and elevated fasting 
blood glucose (≥5.6 mmol/L). Women taking medications for dyslipidaemia, hypertension or 
diabetes were regarded as having dyslipidaemia, hypertension or impaired glucose tolerance, 
respectively. Systolic and diastolic blood pressure readings were performed using a calibrated 
sphygmomanometer, and fasting serum samples were taken for estimation of serum lipid 
profile and blood glucose23. 
 
2.4.Covariates  
The following variables collected at baseline were included in the analysis: age and BMI. They 
were treated as continuous variables.  
 
2.5.Statistical analysis 
Data analysis was performed using Stata software version 13.1 (StataCorp, College Station, 
Texas). Characteristics for participants were assessed using mean and standard deviation (SD) 
or median and interquartile range (IQR) for continuous variables and relative and absolute 
values for categorical variables. 
 
To address potential bias and increase precision in this analysis as a result of missing values, 
multiple imputation was used27. Missing data of some needed variables to calculate number of 
MetS were observed in 9 (0.9%) to 365 (38.3%) women (see online supplementary file Table 
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S1). The approach of multiple imputation followed by deletion28 was followed, imputing 
missing information for all women, but then excluding those with missing data on outcomes. 
Multivariate imputation by chained equations (MICE) was used which assumes that data are 
Missing At Random (MAR).  
The mechanism of missing data was assumed to be MAR because the underlying values 
necessary to calculate MetS that were missing for some women are likely to depend on 
observed data in the Chingford data. The imputation equations included all metabolic 
components, outcome variables, covariates included in this study, as well as additional 
variables available on the dataset including menopause status, pain medication, smoking status, 
alcohol intake, physical activity (times/per week), and occupation (manual/non-manual). 
Logistic regression was used for the binary variables (individual component of MetS). Two 
hundred imputed cycles were performed to generate the data set, and the resulting estimates 
were combined using Rubin’s rules. The imputations were assessed by hand (supplementary 
Tables S2, S3 and S4 compare the distribution and associations with outcome of imputed 
variables in the imputed data set and the observed data (with no imputation)) and by using 
graphical methods. Similar results were observed between imputed and observed data sets. 
Multinomial logistic regression analysis adjusted for age and then for BMI were conducted to 
calculate relative-risk ratios (RRR) and 95% confidence intervals (CI) and assess the effect of 
MetS status, severity of MetS (assessed as the sum of MetS components and analyzed as a 
continuous variable, range 0–5) and each of its individual components on site-specific OA and 
pain (knee and hand). ‘Neither ROA nor pain’ was used as the reference group. Two separate 
analyses were conducted for knee and hand. 
Several sensitivity analyses were conducted. First, a sensitivity analyses was performed to 
assess a more inclusive cohort, comprising only women without joint pain and K/L=0 as the 
reference group. A second sensitivity analysis was performed where each subgroup for specific 
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joint (knee or hand) was adjusted for presence or absence of other OA (knee and/or hand). 
Third, women with 2 or more affected IPJ joints with K/L grade 2 or higher were classified as 
having hand ROA. Finally, to examine whether differences in the phenotype of the different 
hand joints exist 29, associations between MetS and hand OA based on the first carpometacarpal 
joint (CMC) were assessed in isolation. 
 
3. RESULTS 
3.1.Participants’ characteristics 
Of the 1003 eligible women in the Chingford study, 952 (95.0%) women did not have RA and 
had complete data on knee and hand pain and/or radiographic information (Figure 1).  
Demographic and clinical characteristics of included women are shown in Table 1. The median 
(IQR) age was 54 (49-60) years and the prevalence of MetS among the participants was 11.8%. 
The most prevalent MetS component was hypertension (57.2%), followed by low HDL-c 
(19.3%), hypertriglyceridemia (16.6%), high waist circumference (15.7%) and raised fasting 
glucose (8.3%). The prevalence of painful knee and hand ROA was 7.1% and 12.4% 
respectively. 
Distribution of the five components of MetS by joint-specific ROA and pain group are 
described in online supplementary file Tables S5 and S6. Overall, hypertension, abnormal waist 
circumference, triglycerides, HDL-c and fasting glucose (in the context of MetS definition) 
were higher among women with painful knee and/or hand OA. However, higher waist 
circumference was significantly different only among knee OA groups and higher level of 
triglycerides and fasting glucose among IPJ OA groups. 
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3.2.Association between the presence and the number of MetS components and 
painful knee and hand ROA 
Multinomial logistic regression results on the association between the presence and the number 
of MetS components on knee and hand OA are displayed in Table 2. Results from age-adjusted 
analyses indicated that women with MetS had a significantly greater risk of having painful 
knee ROA than those with neither knee ROA nor knee pain. The RRR (95% CI) for ≥three 
MetS components vs no MetS components was 4.3 (1.4-12.4). After adjusting for BMI, 
associations between MetS and painful knee OA were no longer statistically significant (RRR 
(95% CI): 1.3 (0.4-4.4) and 1.0 (0.7-1.3) for ≥three MetS components vs none components and 
number of MetS components, respectively). 
 
There were significant associations between the presence and the number of MetS with IPJ OA 
groups and the association remained after controlling for BMI. Interestingly, RRRs were higher 
for those with ROA (painful or painless) than the group with knee pain only. 
Increase in the number of MetS components resulted in increased risk of painful hand ROA by 
50%. 
 
3.3.Association between individual components of MetS and knee and hand OA 
The age and BMI adjusted associations between individual components of MetS and painful 
knee and IPJ ROA are presented in Figure 2 and 3, respectively.  
High waist circumference was the only metabolic component significantly associated with 
higher risk of painful knee ROA (p<0.001). However, after adjusting for BMI, this association 
became nonsignificant (Figure 2). 
Hypertriglyceridemia, low HDL-c levels, hypertension and high fasting glucose were 
correlated with painful IPJ ROA (Figure 3). Among these factors, high fasting glucose had the 
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strongest correlation with painful IPJ ROA (RRR (95% CI): 3.0 (1.3-7.2)). After adjusting for 
BMI, all factors remained statistically significant except HDL-c. Waist circumference was the 
only component that did not show a statistically significant association with painful IJP ROA 
(RRR (95% CI): 0.9 (0.5-1.5)) 
 
3.4.Sensitivity analyses 
No substantial differences in the results were seen after participants with K/L grade =1 were 
excluded from the reference groups, or after adjusting each model for concurrent OA affecting 
other examined joints (see Supplementary Table S7). In addition, similar results were found 
after women were classified as having hand OA if they presented 2 or more affected IPJ joints 
with a K/L grade of ≥2 (see Supplementary Table S7). 
After re-running the analysis for CMC OA, no association between number of MetS and any 
CMC OA groups were found (see Supplementary Table S8).  
 
4. DISCUSSION 
This study suggests that MetS is associated with painful knee OA, independent of age, in this 
community-based cohort of middle-aged women. However, after adjusting for BMI, this 
association was no longer significant, suggesting that the majority of this association may be 
explained by higher weight. On the other hand, a statistical association between the presence 
and number of MetS and painful IPJ ROA was found even after adjusting for age and BMI. 
When evaluating the five components of MetS separately, high waist circumference was the 
only metabolic component strongly associated with knee OA; however, this association 
became non-significant when BMI was adjusted. Hypertriglyceridaemia, hypertension and 
raised fasting glucose levels were significantly associated with painful IPJ ROA.  
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To our knowledge, this is the first community-based study where there has been additional 
sensitivity analysis adjusting for OA at the other joints (see Supplementary Table 7). A strong 
independent association between hand OA and the risk of developing knee OA has been 
reported in a few independent large population based studies 30-32. This may be due to potential 
confounding in studies looking at MetS and hand OA without adjusting for presence of OA 
affecting lower limbs.  
Previous studies have shown an association between MetS and knee OA, however the 
definition of MetS and OA has not been consistent. The majority of studies have focused on an 
older population and those at higher risk of OA 15,33, therefore our findings may not be directly 
comparable with previous publications. Our findings are consistent with previous studies in 
middle-age populations that have demonstrated an association between MetS and knee OA, 
although this was attenuated and not significant after adjustment for BMI 34,35.  
 
High BMI is a risk factor for both MetS and OA affecting the knee and the hand; although the 
association is strongest for knee OA, which would suggest significant role of loading in weight 
bearing joints5.  
A previous study has suggested that weight loss is an effective way of reducing the risk of 
symptomatic knee OA36. A recently published randomised controlled trial showed that brief 
weight loss interventions offered by GPs in unrelated consultations are cost-effective with 
patients five times more likely to have lost weight a year later37. As we have demonstrated that 
the population with MetS is more likely to have knee OA, this group may benefit from targeted 
weight loss interventions to reduce cardiovascular risk.  
 
The mechanisms underlying the association between metabolic factors and hand OA is unclear. 
This association between the accumulation of metabolic factors and painful hand ROA has not 
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previously been reported. Few studies have studied the association between metabolic factors 
and hand ROA 38-42, however their findings have been contradictory. Strand et. al. 40,42 did not 
find any association between MetS and hand ROA after adjusting for age, sex and BMI. Those 
findings are consistent with the present study for hand ROA without concurrent hand pain. 
However, association between MetS and painful hand ROA was statistically significant in our 
analysis (Figure 3). Dahaghin et. al. 39 showed that diabetes, hypertension and being overweight 
were associated with hand OA, which we did not demonstrate (RRR (95% CI): 2.2 (0.9-5.6), 
0.9 (0.6-1.5) and 0.8 (0.4-1.6) for high fasting glucose levels, hypertension and high waist 
circumference, respectively). These discrepancies may be due to differences in the definitions 
of MetS components, hand OA groups or to the lower prevalence of MetS found in this healthy 
population (11.8%) or differences in the study population (particularly - mean age and race). 
In line with our results, Marshall et. al. 38 identified an association between selected metabolic 
factors, principally dyslipidaemia, and the risk of erosive hand ROA in a population sample of 
symptomatic individuals.  
 
4.1.Strengths and limitations 
To our knowledge, no other community-based study has described the patterns of metabolic 
dysregulation associated with knee and hand OA in middle-aged women. Our group is 
representative of the general population of this age and gender. Participants were not selected 
based on symptomatology or radiographic features and this allows us to have a control 
population (Pain -/ROA -). We used multiple imputation to minimize selection bias and to 
increase precision27.  
Our study has several limitations. First, findings of this study are restricted to middle-age 
women of Caucasian ethnicity. Second, this study is limited by its cross-sectional design and 
our analysis does not indicate causality, but suggests that common pathogenic mechanisms 
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may be involved in women with knee OA, hand OA and MetS. In addition, nowadays a 
substantial proportion of adults who experiencing pain related to knee or hand OA seek medical 
advice, therefore it is important for clinicians to be aware of those associations, especially in a 
view of cardiovascular problems in new users of nonsteroidal medications. Third, our dataset 
had a relatively high proportion of missing values. The use of a multiple imputation procedure 
might be preferable in terms of results validity than complete case analysis27. Distributions of 
the variables with missing data between participants with observed data and those with imputed 
data were compared and similar results were found, which reinforces our results. Fourth, 
current knee and hand pain was assessed on a self-reported joint symptoms questionnaire; 
therefore we cannot verify that joint pain was secondary to OA.. Fifth, some uncontrolled 
parameters such as physical activity and/or diet may have change since this study started in 
1988-1989, therefore, the results may not generalizable to individuals in 2018. However, our 
findings are consistent with recent studies15-17,41 which support that these potential differences 
may not have any impact on the association between number of MetS and site-specific OA. 
Sixth, number of women taking lipids or diabetes medication was smaller. Possible 
explanations for this may be first, women were asking to report their current medication, which 
may have led to recall and/or desirability bias. Second, the diagnostic criteria for diabetes 
mellitus and high blood cholesterol were changed in 1997 and 2002, respectively, 43,44 such 
that conservative definitions of serum fasting glucose, triglycerides and HDL ranges were 
considered. Therefore, some women in this study classified as diabetic or/and with 
dyslipidemia would not have been diagnosed with the disease in 1989-90. 
 
4.2. Conclusions 
In conclusion, data from this study demonstrate that MetS is strongly associated with painful 
IPJ hand OA when compared to the unaffected group. No association was found for knee OA 
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when BMI is taking into account. These findings support the concept that OA affecting 
different joints may have different pathogenic pathways. Further attention to MetS and OA at 
different sites is needed to understand the metabolic phenotype in OA. These findings have 
important implications for public health as better control of metabolic factors may further 
improve quality of life for women of middle age. 
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TABLES 
 
Table 1. Baseline characteristics of women in the Chingford study 
Characteristic Participantsa (n=952) 
Age (years), median (IQR)  54 (49-60) 
BMI (kg/m2), mean (SD) 25.6 ± 4.3 
Waist circumference (cm), mean (SD) 78.0 ± 10.1 
High waist circumference (N=943), n (%)b 148 (15.7) 
Triglycerides (mmol/L), mean (SD) 1.18 ± 0.64 
HDL-cholesterol (mmol/L), mean (SD) 1.72 ± 0.45 
Lipids medication, n (%) 4 (0.4) 
High triglycerides (N=607), n (%)b 101 (16.6) 
Low HDL-cholesterol (N=587), n (%)b 113 (19.3) 
SBP (mmHg), mean (SD) 128.3 ± 20.1 
DBP (mmHg), mean (SD) 78.6 ± 11.4 
BP medication, n (%) 94 (9.9) 
Hypertension (N=933), n (%)b 534 (57.2) 
Glucose (mmol/L), mean (SD) 5.00 ± 0.96 
Diabetes medication, n (%) 3 (0.3) 
High fasting glucose (N=604), n (%)b 50 (8.3) 
IQR, interquartile range; BMI, body mass index; SD, standard deviation; HDL, high-density lipoprotein; SBP, 
systolic blood pressure; DBP, diastolic blood pressure, RA, rheumatoid arthritis 
a
Number of participants without RA and complete data on both outcome measures. 
bPercentage was calculated using the information available on each individual variable.  
High waist circumference: ≥88 cm; high triglycerides: ≥1.7 mmol/L or using lipids medication; low HDL 
cholesterol: <1.3 mmol/L or using lipids medication; hypertension: ≥130/85 mmHg or currently using 
antihypertensive medication; high fasting glucose: ≥5.6 mmol/L or currently using anti-diabetic medication 
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Table 2. Cross-sectional association of presence and number of metabolic syndrome 
(exposure) with joint-specific pain and ROA (outcome) 
Neither ROA nor pain: 
reference category 
Age-adjusted Age and BMI adjusted 
RRR (95% CI) p-value RRR (95% CI) p-value 
Knee    
Presence of MetSa (≥3 vs. 0)     
ROA only  2.2 (0.8-5.9) 0.139 1.0 (0.3-3.4) 0.996 
Pain only  1.5 (0.8-2.6) 0.164 1.1 (0.6-2.2) 0.700 
Painful ROA 4.3 (1.4-12.4) <0.05 1.3 (0.4-4.4) 0.725 
Number of MetSa     
ROA only 1.3 (1.0-1.7) 0.089 1.0 (0.7-1.4) 0.980 
Pain only  1.2 (1.0-1.3) 0.051 1.1 (0.9-1.3) 0.379 
Painful ROA 1.4 (1.1-1.8) <0.005 1.0 (0.7-1.3) 0.990 
Hand (DIP/PIP joints)    
Presence of MetSa (≥3 vs. 0)     
ROA only  2.2 (0.9-5.0) 0.072 2.0 (0.8-5.4) 0.158 
Pain only  0.8 (0.3-1.8) 0.518 0.6 (0.2-1.7) 0.389 
Painful ROA 3.9 (1.7-9.2) <0.005 4.4 (1.7-11.5) <0.005 
Number of MetSa     
ROA only 1.3 (1.0-1.6) <0.05 1.3 (1.0-1.7) 0.069 
Pain only  0.9 (0.7-1.2) 0.536 0.9 (0.7-1.2) 0.374 
Painful ROA 1.4 (1.2-1.8) <0.005 1.5 (1.2-2.0) <0.005 
OA, Osteoarthritis; MetS, Metabolic syndrome; ROA, radiographic osteoarthritis; RR, relative-risk ratio; CI, 
confidence intervals; BMI, Body Mass Index 
aMetS components defined by the National Cholesterol Education Program III are as follows: waist circumference: 
≥88 cm; triglycerides: ≥1.7 mmol/L or using lipids medication; HDL cholesterol: <1.3 mmol/L or using lipids 
medication; blood pressure: ≥130/85 mmHg or currently using antihypertensive medication; fasting glucose: ≥5.6 
mmol/L or currently using anti-diabetic medication. 
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FIGURE LEGENDS 
 
Figure 1. Flow chart of the study 
 
Figure 2. Cross-sectional association between individual components of MetS* (exposure) 
and knee painful ROA versus neither ROA nor pain (outcome) 
OA, Osteoarthritis; MetS, the Metabolic syndrome; ROA, radiographic osteoarthritis; RR, risk ratios; CI, 
confidence intervals; HDL-c, high-density lipoprotein cholesterol; BMI, Body Mass Index 
*MetS components defined by the National Cholesterol Education Program III are as follows: waist 
circumference: ≥88 cm; triglycerides: ≥1.7 mmol/L or using lipids medication; HDL cholesterol: <1.3 mmol/L 
or using lipids medication; hypertension: blood pressure≥130/85 mmHg or currently using antihypertensive 
medication; fasting glucose: ≥5.6 mmol/L or currently using anti-diabetic medication. 
 
Figure 3. Cross-sectional association between individual components of MetS* (exposure) 
and hand painful ROA versus neither ROA nor pain (outcome) 
OA, Osteoarthritis; MetS, the Metabolic syndrome; ROA, radiographic osteoarthritis; RR, risk ratios; CI, 
confidence intervals; HDL-c, high-density lipoprotein cholesterol; BMI, Body Mass Index 
*MetS components defined by the National Cholesterol Education Program III are as follows: waist 
circumference: ≥88 cm; triglycerides: ≥1.7 mmol/L or using lipids medication; HDL cholesterol: <1.3 mmol/L 
or using lipids medication; hypertension; blood pressure≥130/85 mmHg or currently using antihypertensive 
medication; fasting glucose: ≥5.6 mmol/L or currently using anti-diabetic medication. 
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SUPPLEMENTARY DATA 
 
Supplemental Table S1. Number (percent) of women with missing data 
Characteristic N=952a 
Age 0 (0%) 
BMI 0 (0%) 
Waist circumference 9 (0.9%) 
Triglycerides 345 (36.2%) 
HDL-cholesterol 365 (38.3%) 
Hypertension 19 (2.0%) 
Fasting glucose 348 (36.6%) 
BMI, Body Mass Index; HDL, high-density lipoprotein; ROA, Radiographic Osteoarthritis; SBP, Systolic blood 
pressure; DBP, Diastolic blood pressure; RA, rheumatoid arthritis 
a Women with RA and/or incomplete data on both outcomes (n=952). 
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Supplemental Table S2. Distribution of MetS* individual components on available/complete cases and 
imputed data 
Characteristic ACa CCb (n=567) 
Imputed datac (n=952) 
Proportion 
High waist circumference (n=943), % 15.7 15.3 15.6 
High triglycerides (n=607), % 16.6 16.9 18.4 
Low HDL-cholesterol (n=587), % 19.3 19.1 19.8 
Hypertension (n=933), % 57.2 52.9 57.2 
High fasting glucose (n=604), % 8.3 8.3 9.4 
MetS, Metabolic syndrome; AC, available cases; CC, complete cases; HDL, high-density lipoprotein; SBP, Systolic blood pressure; 
DBP, Diastolic blood pressure 
*High waist circumference: ≥88 cm; high triglycerides: ≥1.7 mmol/L or using lipids medication; low HDL cholesterol: <1.3 mmol/L 
or using lipids medication; hypertension: SBP/DBP ≥130/85 mmHg or currently using antihypertensive medication; high fasting 
glucose: ≥5.6 mmol/L or currently using anti-diabetic medication. 
aWomen with available cases on each individual component of MetS included in the analysis (samples vary depending of each 
variable) 
bWomen who had complete information on all individual component of MetS and covariates included in the analysis (n=567) 
cImputed data after excluding women with RA and/or incomplete data on both outcomes (n=952).  
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Supplemental Table S3. Effect size of each individual component of MetS* (Available/Complete cases vs. 
missing data) with knee OA 
Neither ROA nor pain: 
reference category 
AC CC (n=567) Imputed data (n=952) 
Unadjusted  
RRR (95%CI) 
Unadjusted 
RRR (95%CI) 
Age-adjusted 
RRR (95%CI) 
Unadjusted 
RRR (95%CI) 
Age-Adjusted 
RRR (95%CI) 
High WC (n=943)      
ROA only 2.5 (1.4-4.6) 2.5 (1.0-6.3) 2.5 (1.0-6.2) 2.5 (1.4-4.5) 2.2 (1.2-4.1) 
Pain only 1.5 (1.0-2.2) 1.2 (0.7-2.0) 1.2 (0.7-2.0) 1.5 (1.0-2.3) 1.5 (1.0-2.2) 
Painful OA 4.7 (2.7-8.3) 4.6 (2.3-9.3) 4.4 (2.1-9.1) 4.5 (2.6-8.0) 4.1 (2.3-7.2) 
High triglycerides (n=607)      
ROA only 0.9 (0.3-2.7) 0.7 (0.2-2.3) 0.6 (0.2-2.1) 1.1 (0.4-3.1) 0.9 (0.3-2.5) 
Pain only 1.3 (0.8-2.1) 1.4 (0.9-2.2) 1.3 (0.8-2.1) 1.3 (0.8-2.0) 1.3 (0.8-2.0) 
Painful OA 1.4 (0.6-3.1) 1.3 (0.6-3.0) 1.0 (0.4-2.4) 1.2 (0.6-2.6) 1.0 (0.4-2.1) 
Low HDL-c (n=587)      
ROA only 1.3 (0.5-3.2) 1.3 (0.5-3.5) 1.3 (0.5-3.5) 1.4 (0.6-3.4) 1.4 (0.6-3.3) 
Pain only 1.1 (0.7-1.7) 1.1 (0.7-1.8) 1.1 (0.7-1.8) 1.1 (0.7-1.7) 1.1 (0.7-1.7) 
Painful OA 2.0 (1.0-4.0) 1.9 (0.9-4.0) 1.9 (0.9-4.1) 1.8 (0.9-3.6) 1.8 (0.9-3.6) 
Hypertension (n=933)      
ROA only 2.0 (1.2-3.5) 0.8 (0.4-1.8) 0.6 (0.3-1.5) 2.0 (1.2-3.5) 1.4 (0.8-2.5) 
Pain only 1.3 (1.0-1.8) 1.3 (0.9-1.9) 1.2 (0.8-1.8) 1.3 (1.0-1.7) 1.3 (0.9-1.8) 
Painful OA 2.2 (1.3-3.9) 4.3 (1.9-9.6) 3.0 (1.3-7.1) 2.3 (1.3-4.0) 1.6 (0.9-2.9) 
High glucose (n=604)      
ROA only 2.2 (0.7-6.8) 1.0 (0.2-4.7) 1.0 (0.2-4.4) 2.4 (0.8-6.9) 2.1 (0.7-6.1) 
Pain only 1.3 (0.6-2.5) 1.2 (0.6-2.4) 1.2 (0.6-2.4) 1.3 (0.7-2.5) 1.3 (0.7-2.5) 
Painful OA 2.5 (1.0-6.2) 2.7 (1.1-6.7) 2.3 (0.9-5.8) 2.1 (0.8-5.2) 1.8 (0.7-4.6) 
MetS, Metabolic syndrome; OA, Osteoarthritis; AC, available cases; CC, complete cases; IQR, interquartile range; HDL, high-density 
lipoprotein; SBP, Systolic blood pressure; DBP, Diastolic blood pressure 
*High waist circumference: ≥88 cm; high triglycerides: ≥1.7 mmol/L or using lipids medication; low HDL cholesterol: <1.3 mmol/L 
or using lipids medication; hypertension: SBP/DBP ≥130/85 mmHg or currently using antihypertensive medication; high fasting 
glucose: ≥5.6 mmol/L or currently using anti-diabetic medication. 
aWomen with available cases on each individual component of MetS included in the analysis (samples vary depending of each 
variable) 
bWomen who had complete information on all individual components of MetS and covariates included in the analysis (n=567) 
cImputed data after excluding women with RA and/or incomplete data on both outcomes (n=952).  
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Supplemental Table S4. Effect size of each individual component of MetS* (Available/Complete cases vs. 
missing data) with hand OA 
Neither ROA nor pain: 
reference category 
AC CC (n=567) Imputed data (n=952) 
Unadjusted  
RRR (95%CI) 
Unadjusted 
RRR (95%CI) 
Age-adjusted 
RRR (95%CI) 
Unadjusted 
RRR (95%CI) 
Age-Adjusted 
RRR (95%CI) 
High WC (n=943)      
ROA only 1.5 (0.9-2.4) 2.0 (1.0-4.0) 1.9 (0.9-3.9) 1.4 (0.9-2.4) 1.1 (0.7-2.0) 
Pain only 0.8 (0.4-1.4) 0.7 (0.3-1.6) 0.7 (0.3-1.6) 0.8 (0.4-1.4) 0.7 (0.4-1.3) 
Painful OA 1.4 (0.9-2.4) 1.3 (0.6-2.7) 1.2 (0.6-2.6) 1.4 (0.9-2.4) 1.1 (0.7-1.9) 
High triglycerides (n=607)      
ROA only 3.0 (1.6-5.7) 2.6 (1.3-5.1) 2.0 (1.0-4.1) 2.7 (1.4-5.2) 2.1 (1.1-4.3) 
Pain only 1.3 (0.6-2.5) 1.2 (0.6-2.5) 1.2 (0.6-2.4) 1.3 (0.6-2.5) 1.2 (0.6-2.4) 
Painful OA 3.1 (1.7-5.7) 2.4 (1.3-4.6) 1.8 (0.9-3.6) 3.0 (1.6-5.4) 2.3 (1.2-4.3) 
Low HDL-c (n=587)      
ROA only 1.8 (1.0-3.5) 1.8 (0.9-3.5) 1.9 (0.9-3.9) 1.8 (0.9-3.3) 1.8 (0.9-3.5) 
Pain only 0.9 (0.5-1.8) 0.9 (0.5-1.9) 0.9 (0.5-1.9) 0.9 (0.5-1.8) 0.9 (0.5-1.8) 
Painful OA 1.8 (0.9-3.2) 1.5 (0.8-2.9) 1.7 (0.8-3.3) 1.9 (1.0-3.4) 1.9 (1.0-3.7) 
Hypertension (n=933)      
ROA only 1.8 (1.2-2.8) 2.5 (1.3-4.6) 1.1 (0.6-2.3) 1.8 (1.2-2.8) 1.0 (0.6-1.6) 
Pain only 0.9 (0.6-1.4) 1.2 (0.7-1.9) 1.0 (0.6-1.8) 0.9 (0.6-1.4) 0.8 (0.5-1.2) 
Painful OA 3.2 (2.0-5.1) 4.1 (2.2-7.9) 1.9 (0.9-3.7) 3.2 (2.0-5.1) 1.7 (1.0-2.8) 
High glucose (n=604)      
ROA only 3.1 (1.3-6.9) 3.4 (1.5-7.8) 3.2 (1.3-7.9) 2.7 (1.2-6.0) 2.4 (1.0-5.8) 
Pain only 0.9 (0.3-2.8) 1.0 (0.3-3.0) 1.0 (0.3-3.0) 0.9 (0.3-2.6) 0.9 (0.3-2.6) 
Painful OA 3.7 (1.7-7.8) 3.5 (1.6-7.6) 3.3 (1.4-7.7) 3.4 (1.6-7.1) 3.1 (1.3-7.2) 
MetS, Metabolic syndrome; OA, Osteoarthritis; AC, available cases; CC, complete cases; IQR, interquartile range; HDL, high-density 
lipoprotein; SBP, Systolic blood pressure; DBP, Diastolic blood pressure 
*High waist circumference: ≥88 cm; high triglycerides: ≥1.7 mmol/L or using lipids medication; low HDL cholesterol: <1.3 mmol/L 
or using lipids medication; hypertension: SBP/DBP ≥130/85 mmHg or currently using antihypertensive medication; high fasting 
glucose: ≥5.6 mmol/L or currently using anti-diabetic medication. 
aWomen with available cases on each individual component of MetS included (samples vary depending of each variable) 
bWomen who had complete information on all individual components of MetS and covariates included in the analysis (n=567) 
cImputed data after excluding women with RA and/or incomplete data on both outcomes (n=952).  
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Supplemental Table S5. Women characteristics across knee status categories (n=952). 
Characteristic 
Neither ROA nor 
pain (n=553) 
ROA only 
(n=70) 
Pain only 
(n=261) 
Painful ROA 
(n=68) 
p-value 
Age, years; median(IQR) 53 (48-59) 58 (51-62) 53 (49-59) 58 (54-62) <0.001 
Missing, n (%) - - - -  
BMI, kg/m2, mean ± SD 25.0 ± 3.9 27.3 ± 4.7 25.8 ± 4.3 28.8 ± 5.2 <0.005 
Missing, n (%) - - - -  
High waist circumference, n (%) 64 (11.6) 17 (24.3) 42 (16.1) 25 (36.8) <0.001 
Missing, n (%) 3 (0.5) 1 (1.4) 2 (0.8) 3 (4.4)  
High Triglycerides, n (%) 54 (9.8) 4 (5.7) 34 (13.0) 9 (13.2) 0.607 
Missing, n (%) 198 (35.8) 41 (58.6) 83 (31.8) 23 (33.8)  
Low HDL-cholesterol, n (%) 62 (11.2) 6 (8.6) 32 (12.3) 13 (19.1) 0.277 
Missing, n (%) 206 (37.3) 42 (60.0) 92 (35.3) 25 (36.8)  
Hypertension, n (%) 289 (52.3) 48 (68.6) 149 (57.1) 48 (70.6) <0.005 
Missing, n (%) 7 (1.3) 1 (1.4) 10 (3.8) 1 (1.5)  
High fasting glucose, n (%) 24 (4.3) 4 (5.7) 15 (5.8) 7 (10.3) 0.152 
Missing, n (%) 201 (36.4) 41 (58.6) 83 (31.8) 23 (33.8)  
OA, Osteoarthritis; ROA, radiographic osteoarthritis; IRQ, interquartile range; SD, standard deviation; HDL, high-density 
lipoprotein; SBP, Systolic blood pressure; DBP, Diastolic blood pressure 
High waist circumference: ≥88 cm; high triglycerides: ≥1.7 mmol/L or using lipids medication; low HDL cholesterol: <1.3 mmol/L 
or using lipids medication; hypertension: SBP/DBP ≥130/85 mmHg or currently using antihypertensive medication; high fasting 
glucose: ≥5.6 mmol/L or currently using anti-diabetic medication. 
Values of p-value refer to differences between pain and ROA groups. 
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Supplemental Table S6. Women characteristics across hand status categories (n=952). 
Characteristic 
Neither ROA nor 
pain (n=604) 
ROA only 
(n=111) 
Pain only 
(n=119) 
Painful ROA 
(n=118) 
p-value 
Age, years 52 (48-58) 59 (54-62) 53 (49-58) 60 (55-63) <0.001 
Missing, n (%) - - - -  
BMI, kg/m2 25.4 ± 4.4 26.4 ± 4.9 25.7 ± 3.8 26.1 ± 4.2 0.103 
Missing, n (%) - - - -  
High waist circumference, n (%) 89 (14.7) 22 (19.8) 14 (11.8) 23 (19.5) 0.177 
Missing, n (%) 3 (0.5) 2 (1.8) 1 (0.8) 3 (2.5)  
High Triglycerides, n (%) 53 (8.8) 17 (15.3) 11 (9.2) 20 (17.0) <0.001 
Missing, n (%) 188 (31.1) 55 (50.0) 48 (40.3) 54 (45.8)  
Low HDL-cholesterol, n (%) 70 (11.6) 15 (13.5) 11 (9.2) 17 (14.4) 0.101 
Missing, n (%) 202 (33.4) 57 (51.4) 51 (42.9) 55 (46.6)  
Hypertension, n (%) 311 (51.5) 72 (64.9) 59 (49.6) 92 (78.0) <0.001 
Missing, n (%) 14 (2.3) 3 (2.7) 2 (1.7) 0 (0)  
High fasting glucose, n (%) 25 (4.1) 9 (8.1) 4 (3.4) 12 (10.2) <0.001 
Missing, n (%) 189 (31.3) 56 (50.5) 48 (40.3) 55 (46.6)  
OA, Osteoarthritis; ROA, radiographic osteoarthritis; IRQ, interquartile range; SD, standard deviation; HDL, high-density 
lipoprotein; SBP, Systolic blood pressure; DBP, Diastolic blood pressure 
High waist circumference: ≥88 cm; high triglycerides: ≥1.7 mmol/L or using lipids medication; low HDL cholesterol: <1.3 mmol/L 
or using lipids medication; hypertension: SBP/DBP ≥130/85 mmHg or currently using antihypertensive medication; high fasting 
glucose: ≥5.6 mmol/L or currently using anti-diabetic medication. 
Values of p-value refer to differences between pain and ROA groups. 
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Supplemental Table S7. Cross-sectional association of number of MetS* (exposure) with 
joint-specific pain and ROA (outcome) 
Neither ROA nor pain: reference category 
Knee Hand 
RRR (95% CI) RRR (95% CI) 
A) Excluding women with K/L grade =1   
Number of MetS   
ROA only 1.0 (0.7-1.4) 1.3 (1.0-1.7) 
Pain only  1.1 (0.9-1.3) 0.9 (0.7-1.2) 
Painful ROA 1.0 (0.7-1.3) 1.6 (1.2-2.0) 
B) Adjusting for OA affecting other joint   
Number of MetS   
ROA only 1.0 (0.7-1.4) 1.3 (1.0-1.7) 
Pain only  1.1 (0.9-1.3) 0.9 (0.7-1.1) 
Painful ROA 1.0 (0.7-1.3) 1.5 (1.2-2.0) 
C) IPJ OA affecting 2 or more jointsa -  
Number of MetS -  
ROA only - 1.1 (0.8-1.6) 
Pain only  - 1.0 (0.8-1.2) 
Painful ROA - 1.4 (1.1-1.8) 
OA, Osteoarthritis; MetS, the Metabolic syndrome; ROA, radiographic osteoarthritis; RR, risk ratios; CI, 
confidence intervals; HDL-c, high-density lipoprotein cholesterol. 
Adjusted for age and BMI 
*MetS components defined by the National Cholesterol Education Program III are as follows: waist 
circumference: ≥88 cm; triglycerides: ≥1.7 mmol/L or using lipids medication; HDL cholesterol: <1.3 mmol/L or 
using lipids medication; blood pressure: ≥130/85 mmHg or currently using antihypertensive medication; fasting 
glucose: ≥5.6 mmol/L or currently using anti-diabetic medication. 
aReference category: Women presenting less than 2 IPJ joints affected with a K/L grade of ≥2 and without any 
joint pain. 
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Supplemental Table S8. Cross-sectional association between number of MetS* (exposure) 
with CMC pain and ROA (outcome)  
Neither ROA nor pain: reference category 
CMC  
RRR (95% CI) p-value 
Number of MetS   
ROA only 0.9 (0.7-1.2) 0.609 
Pain only  1.0 (0.7-1.2) 0.726 
Painful ROA 0.9 (0.7-1.2) 0.597 
CMC, first carpometacarpal; OA, Osteoarthritis; MetS, the Metabolic syndrome; ROA, radiographic 
osteoarthritis; RR, risk ratios; CI, confidence intervals; HDL-c, high-density lipoprotein cholesterol. 
Adjusted for age and BMI 
*MetS components defined by the National Cholesterol Education Program III are as follows: waist 
circumference: ≥88 cm; triglycerides: ≥1.7 mmol/L or using lipids medication; HDL cholesterol: <1.3 mmol/L or 
using lipids medication; blood pressure: ≥130/85 mmHg or currently using antihypertensive medication; fasting 
glucose: ≥5.6 mmol/L or currently using anti-diabetic medication. 
 
 
